Skip to main content

Advertisement

Log in

Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child-A NASH-related cirrhosis

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Purpose

Bariatric surgery can improve non-alcoholic fatty liver disease (NAFLD). Yet data on the effect on fibrosis are insufficient and controversial. This work endeavored to evaluate the safety of laparoscopic sleeve gastrectomy (LSG) in cases that have compensated non-alcoholic steatohepatitis (NASH)-related cirrhosis and its impact on fibrosis stage.

Methods

The current prospective work involved 132 cases with Child-A NASH-related cirrhosis suffering from morbid obesity scheduled for LSG. They were subjected to preoperative assessment, wedge biopsy, and ultrasound-guided true-cut liver biopsy after 30 months. Patients were included if proved to have F4 fibrosis initially. The liver condition was assessed based on the NALFD Activity Score (NAS). The primary outcome measure was the impact of LSG on fibrosis stage and its relation to weight loss.

Results

The analysis included only 71 patients who completed the 30-month follow-up period. By the end of the follow-up interval, there was a substantial weight loss with a reasonable resolution of comorbidities. The median NAS decreased significantly from 6 (1–8) to 3 (0–6) after surgery. Fibrosis score regressed to F2 in 19 patients (26.8%) and F3 in 29 (40.8%). Patients with improved scores had a significantly higher amount of weight loss (p < 0.001). Improvement was more frequent in males (p = 0.007). By 30 months after treatment, 53.8% of cases with borderline NASH and 36.8% of those with probable NASH showed complete resolution, and 44.7% of patients with NASH showed improvement. Steatosis improved in 74.6% of patients (p < 0.001).

Conclusion

In patients with NASH-related liver cirrhosis of Child class A, LSG may be a secure approach for the management of morbid obesity. It has a long-term benefit for both obesity and liver condition with significant improvement of steatosis, steatohepatitis, and fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K et al (2017) Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377:13–27

    Article  Google Scholar 

  2. Blachier M, Leleu H, Peck-Radosavljevic M, Valla D-C, Roudot-Thoraval F (2013) The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 58:593–608

    Article  Google Scholar 

  3. Fabbrini E, Sullivan S, Klein S (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51:679–689

    Article  CAS  Google Scholar 

  4. Rastogi A, Shasthry SM, Agarwal A, Bihari C, Jain P, Jindal A et al (2017) Non-alcoholic fatty liver disease: histological scoring systems: a large cohort single-center, evaluation study. Acta Pathol Microbiol Immunol Scand 125:962–973

    Article  CAS  Google Scholar 

  5. Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, et al (2009) The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess Winch Engl 13:1–190, 215–357, iii–iv

  6. Aguilar-Olivos NE, Almeda-Valdes P, Aguilar-Salinas CA, Uribe M, Méndez-Sánchez N (2016) The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome. Metabolism 65:1196–1207

    Article  CAS  Google Scholar 

  7. Laursen TL, Hagemann CA, Wei C, Kazankov K, Thomsen KL, Knop FK et al (2019) Bariatric surgery in patients with non-alcoholic fatty liver disease—from pathophysiology to clinical effects. World J Hepatol 11:138–149

    Article  Google Scholar 

  8. Parker BM, Wu J, You J, Barnes DS, Yerian L, Kirwan JP et al (2017) Reversal of fibrosis in patients with nonalcoholic steatohepatosis after gastric bypass surgery. BMC Obes 4:32

    Article  Google Scholar 

  9. Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, Mendez-Sanchez N, Lizardi-Cervera J, Uribe M (2010) Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev 2010:CD007340

    PubMed Central  Google Scholar 

  10. Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK (2008) Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 6:1396–1402

    Article  Google Scholar 

  11. Moretto M, Kupski C, da Silva VD, Padoin AV, Mottin CC (2012) Effect of bariatric surgery on liver fibrosis. Obes Surg 22:1044–1049

    Article  Google Scholar 

  12. Kral JG, Thung SN, Biron S, Hould F-S, Lebel S, Marceau S et al (2004) Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 135:48–58

    Article  Google Scholar 

  13. Stratopoulos C, Papakonstantinou A, Terzis I, Spiliadi C, Dimitriades G, Komesidou V et al (2005) Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg 15:1154–1160

    Article  Google Scholar 

  14. Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R et al (2009) Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 137:532–540

    Article  CAS  Google Scholar 

  15. Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA, NASH Clinical Research Network (CRN) (2011) Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 53:810–820

    Article  CAS  Google Scholar 

  16. Jan A, Narwaria M, Mahawar KK (2015) A systematic review of bariatric surgery in patients with liver cirrhosis. Obes Surg 25:1518–1526

    Article  Google Scholar 

  17. Mosko JD, Nguyen GC (2011) Increased perioperative mortality following bariatric surgery among patients with cirrhosis. Clin Gastroenterol Hepatol 9:897–901

    Article  Google Scholar 

  18. Goh GB-B, Schauer PR, McCullough AJ (2018) Considerations for bariatric surgery in patients with cirrhosis. World J Gastroenterol 24:3112–3119

    Article  Google Scholar 

  19. Berzigotti A, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Morillas R et al (2011) Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology 54:555–561

    Article  Google Scholar 

  20. Cazzo E, Gestic MA, Utrini MP, Chaim FDM, Callejas-Neto F, Pareja JC et al (1992) Bariatric surgery in individuals with liver cirrhosis: a narrative review. Rev Assoc Medica Bras 2017(63):190–194

    Google Scholar 

  21. Klein S, Mittendorfer B, Eagon JC, Patterson B, Grant L, Feirt N et al (2006) Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology 130:1564–1572

    Article  CAS  Google Scholar 

  22. Viana EC, Araujo-Dasilio KL, Miguel GPS, Bressan J, Lemos EM, Moyses MR et al (2013) Gastric bypass and sleeve gastrectomy: the same impact on IL-6 and TNF-α. Prospective clinical trial. Obes Surg 23:1252–1261

    Article  Google Scholar 

  23. Caiazzo R, Lassailly G, Leteurtre E, Baud G, Verkindt H, Raverdy V et al (2014) Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg 260:893–899

    Article  Google Scholar 

  24. Taitano AA, Markow M, Finan JE, Wheeler DE, Gonzalvo JP, Murr MM (2015) Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg 19:429–437

    Article  Google Scholar 

  25. Tai C-M, Huang C-K, Hwang J-C, Chiang H, Chang C-Y, Lee C-T et al (2012) Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients. Obes Surg 22:1016–1021

    Article  Google Scholar 

  26. Praveen Raj P, Gomes RM, Kumar S, Senthilnathan P, Karthikeyan P, Shankar A et al (2015) The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: “NASHOST” prospective observational trial. Surg Obes Relat Dis 11:1315–1322

    Article  CAS  Google Scholar 

  27. Froylich D, Corcelles R, Daigle C, Boules M, Brethauer S, Schauer P (2016) Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study. Surg Obes Relat Dis 12:127–131

    Article  Google Scholar 

  28. Manco M, Mosca A, De Peppo F, Caccamo R, Cutrera R, Giordano U et al (2017) The benefit of sleeve gastrectomy in obese adolescents on nonalcoholic steatohepatitis and hepatic fibrosis. J Pediatr 180(31–37):e2

    Google Scholar 

  29. Garg H, Aggarwal S, Yadav R, Datta Gupta S, Agarwal L et al (2018) Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. Surg Obes Relat Dis 14:81–91

    Article  Google Scholar 

  30. Lassailly G, Caiazzo R, Buob D, Pigeyre M, Verkindt H, Labreuche J et al (2015) Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology 149:379–388

    Article  Google Scholar 

  31. Furuya CK, Oliveira CPMSD, Mello ESD, Faintuch J, Raskovski A, Matsuda M et al (2007) Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol 22:510–514

    Article  CAS  Google Scholar 

  32. de Almeida SR, Savassi Rocha PR, Dias Sanches M, Rios Leite VH, da Silva RAP, Costa Diniz MT et al (2006) Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity. Obes Surg 16:270–278

    Article  Google Scholar 

  33. Keshishian A, Zahriya K, Willes EB (2005) Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months. Obes Surg 15:1418–1423

    Article  Google Scholar 

  34. Rebibo L, Gerin O, Verhaeghe P, Dhahri A, Cosse C, Regimbeau J-M (2014) Laparoscopic sleeve gastrectomy in patients with NASH-related cirrhosis: a case-matched study. Surg Obes Relat Dis 10:405–410

    Article  Google Scholar 

  35. Takata MC, Campos GM, Ciovica R, Rabl C, Rogers SJ, Cello JP et al (2008) Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis 4:159–164

    Article  Google Scholar 

  36. Shimizu H, Phuong V, Maia M, Kroh M, Chand B, Schauer PR et al (2013) Bariatric surgery in patients with liver cirrhosis. Surg Obes Relat Dis 9:1–6

    Article  Google Scholar 

  37. Puggioni A, Wong LL (2003) A meta-analysis of laparoscopic cholecystectomy in patients with cirrhosis. J Am Coll Surg 197:921–926

    Article  Google Scholar 

  38. Leyba JL, Aulestia SN, Llopis SN (2011) Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the treatment of morbid obesity. A prospective study of 117 patients. Obes Surg 21:212–216

    Article  Google Scholar 

  39. Helmiö M, Victorzon M, Ovaska J, Leivonen M, Juuti A, Jaser N et al (2012) SLEEVEPASS: a randomized prospective multicenter study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: preliminary results. Surg Endosc 26:2521–2526

    Article  Google Scholar 

  40. Chouillard EK, Karaa A, Elkhoury M, Greco VJ, Intercontinental Society of Natural Orifice, Endoscopic, and Laparoscopic Surgery (i-NOELS) (2011) Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity: case-control study. Surg Obes Relat Dis 7:500–505

    Article  Google Scholar 

  41. Klebanoff MJ, Corey KE, Samur S, Choi JG, Kaplan LM, Chhatwal J et al (2019) Cost-effectiveness analysis of bariatric surgery for patients with nonalcoholic steatohepatitis cirrhosis. JAMA Netw Open 2(2):e190047

    Article  Google Scholar 

Download references

Funding

This study was supported by the authors. No any other fund was received.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmed Abdallah Salman.

Ethics declarations

Disclosure

Mohamed Abdalla Salman, Hani Maurice Sabri Mikhail, Mohammed A. Nafea, Ahmed Abd El Aal Sultan, Hossam E. Elshafey, Mohamed Tourky, Abeer Awad, Tarek Elsayed Abouelregal, Reham Abdelghany Ahmed, Omar Ashoush, Alhoussein Alsayed AbdelAal, Hossam El-Din Shaaban, Mohamed Atallah, Mohamed Yousef, Ahmed Abdallah Salman have no conflict of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salman, M.A., Mikhail, H.M.S., Nafea, M.A. et al. Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child-A NASH-related cirrhosis. Surg Endosc 35, 1269–1277 (2021). https://doi.org/10.1007/s00464-020-07498-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-020-07498-4

Keywords

Navigation